Adult Burkitt lymphoma- an Island between lymphomas and leukemias

Background: Burkitt lymphoma is a rare, aggressive and rapidly fatal, B-cell non-Hodgkin's lymphoma. It has an incidence of 0.4/100,000 age-adjusted to the USA standard population. Here we describe the case of a 77-year-old patient who presented with Burkitt lymphoma. Case: A 77-year-old male p...

Full description

Saved in:
Bibliographic Details
Main Authors: James Turro (Author), Pratiksha Singh (Author), Manbeer Singh Sarao (Author), Satish Tadepalli (Author), Pramil Cheriyath (Author)
Format: Book
Published: Greater Baltimore Medical Center, 2019-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_856c92c9f32c42699c7cdeb2d002cbb9
042 |a dc 
100 1 0 |a James Turro  |e author 
700 1 0 |a Pratiksha Singh  |e author 
700 1 0 |a Manbeer Singh Sarao  |e author 
700 1 0 |a Satish Tadepalli  |e author 
700 1 0 |a Pramil Cheriyath  |e author 
245 0 0 |a Adult Burkitt lymphoma- an Island between lymphomas and leukemias 
260 |b Greater Baltimore Medical Center,   |c 2019-01-01T00:00:00Z. 
500 |a 2000-9666 
500 |a 10.1080/20009666.2019.1574545 
520 |a Background: Burkitt lymphoma is a rare, aggressive and rapidly fatal, B-cell non-Hodgkin's lymphoma. It has an incidence of 0.4/100,000 age-adjusted to the USA standard population. Here we describe the case of a 77-year-old patient who presented with Burkitt lymphoma. Case: A 77-year-old male presented to his primary care physician with fatigue and listlessness and was referred to the hospital with a white blood cell count (WBC)-23.7 K/uL (neutrophils 37%, lymphocyte 11%, blasts 9%) and platelets-19 K/uL. During his stay in the hospital, repeat investigations revealed WBC-29.9 K/uL (neutrophils 22%, lymphocyte 27%, atypical lymphocytes 5%, blasts 20%) and platelets-10 K/uL with no evidence of mucosal bleeds, neck or abdominal masses or generalized lymphadenopathy. Bone marrow aspirate revealed the presence of MYC rearrangements (8q24) on flow cytometry and fluorescent in-situ hybridization (FISH), indicative but not typical of BL. He was transfused with platelets due to a rapidly deteriorating platelet count and episodes of epistaxis. He was discharged after four days with a plan of outpatient chemotherapy over a period of 4 months. An Ommaya reservoir was placed in the right ventricle for intrathecal chemotherapy. After four months of chemotherapy, computerized tomography of the chest, abdomen, and pelvis confirmed remission. A magnetic resonance imaging of the brain a month after completion of chemotherapy revealed metastatic lymphoma in the temporal, parietal and occipital lobes. He was discharged to hospice for palliative care. Conclusion: Unconventional presentations, as seen in our case of a leukemia-like picture in the absence of a bulky disease, are the quagmire that might delay aggressive management and result in poorer outcomes. 
546 |a EN 
690 |a Lymphoma 
690 |a Burkitt 
690 |a non-hodgkins 
690 |a leukemia 
690 |a immunoglobulin 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Journal of Community Hospital Internal Medicine Perspectives, Vol 9, Iss 1, Pp 25-28 (2019) 
787 0 |n http://dx.doi.org/10.1080/20009666.2019.1574545 
787 0 |n https://doaj.org/toc/2000-9666 
856 4 1 |u https://doaj.org/article/856c92c9f32c42699c7cdeb2d002cbb9  |z Connect to this object online.